Public funding for transformative drugs: the case of sofosbuvir.

Barenie, Rachel E; Avorn, Jerry; Tessema, Frazer A; Kesselheim, Aaron S

Barenie, Rachel E; Avorn, Jerry; Tessema, Frazer A; Kesselheim, Aaron S.

Afiliação

Barenie RE; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA. Electronic address: rbarenie@bwh.harvard.edu.
Avorn J; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA.
Tessema FA; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA.
Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA.

Drug Discov Today ; 26(1): 273-281, 2021 01.

Article em En | MEDLINE | ID: mdl-33011345

Assuntos

Desenvolvimento de Medicamentos; Financiamento Governamental; Hepatite C Crônica/tratamento farmacológico; Sofosbuvir/economia; Antivirais/economia; Antivirais/farmacologia; Custos de Medicamentos; Desenvolvimento de Medicamentos/economia; Desenvolvimento de Medicamentos/métodos; Financiamento Governamental/métodos; Financiamento Governamental/estatística & dados numéricos; Humanos; National Institutes of Health (U.S.)/economia; Sofosbuvir/farmacologia; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C Crônica / Financiamento Governamental / Sofosbuvir / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Drug Discov Today Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google